Raj Makam, co-portfolio manager for Oaktree Capital’s middle-market finance group, discusses the dangers that may await investors in the overheating US direct lending space
Institutional investors are taking a closer look at the back-office operations of fund managers in what appears to be a new normal for GP-LP relations. Service providers are circling
KKR has named Sharon Yang, who has worked on the firm’s private equity, growth equity and real estate strategies in Asia, as a senior investor in the region in its impact investment division.
The Carlyle Group has appointed John Kim (pictured), previously of Goldman Sachs, as a managing director in its Asia buyout team and head of all investment activity in Korea.
Hahn & Company has closed its third Korea-focused buyout fund with $3.2 billion in commitments – the largest vehicle ever raised by an independent manager for investment solely in the country.
Mekong Capital has launched its fifth private equity fund focused on the Vietnam middle market. A hard cap has been set at $250 million.
Northstar Group made its name through a series of consumer, financial services and commodities plays in a nascent Indonesian market. Technology is likely to define the firm’s next chapter
Tommy Teo, a former executive director at Northstar Group, is setting up the Asian headquarters for Vulcan Capital, a philanthropic but returns-focused firm created by the late Microsoft co-founder Paul Allen
Japan’s corporate carve-out opportunity set is expanding as smaller firms begin to follow the example of conglomerates, according to domestic mid-market GP Integral Corporation.
Capital-flooded markets and rising pressures to deploy have precipitated more flexible investment strategies in private equity. GPs must be careful when crossing between asset classes
LGT Group aims to create new inroads for global investors looking to enter the impact space by acquiring Aspada, an Indian platform focused on digital inclusion and small business finance
Michael Granoff, founder and CEO of Pomona Capital, discusses raising capital from Asian LPs, how GPs can be differentiated in a crowded secondaries market, and why he’s not keen on fund restructurings
Japanese mid-market buyout firm Tokio Marine Capital is spinning out from its corporate parent to form an independent investment manager known as T Capital Partners.
Lightbox Ventures has raised $209.3 million for its third India-focused fund, exceeding an initial target of $200 million.
Hiro Hirano and Ashish Shastry, who lead KKR’s operations in Japan and Southeast Asia, respectively, have been appointed co-heads of private equity across the region.
Reform efforts in China’s state-owned enterprise space have experimented in mixed ownership with mixed results. Private equity investors see significant opportunity but must proceed with caution
Vertex China, a venture capital firm affiliated to Temasek Holdings-owned Vertex Holdings, has closed its fourth fund on target at $275 million.
500 Startups has teamed up with a unit of the United Nations to launch an impact-focused start-up accelerator in Indonesia.
The premium traditionally paid for deal-making talent in China over other Asian jurisdictions is narrowing and in some cases has turned into a deficit – in what might be seen as evidence of GPs looking to strengthen their coverage beyond the region’s...
Guaranteed minimum return clauses, and their impact on entrepreneurs, have drawn renewed scrutiny in Indian private equity. Investors say a reassessment of their contribution to value-add is long overdue
An exit lag and difficulties raising money for renminbi funds in China has created a novel opening for secondaries investors comfortable moving assets from one currency to another
Sky9 Capital, a VC firm established by former Lightspeed China executive Ron Cao, has closed its second venture fund at $321 million and also raised $119 million for a growth vehicle.
The boom in LP appetite for co-investment has made it harder to secure access to deals and created adverse selection risk as private equity firms push beyond their comfort zone, investors told the AVCJ Korea Forum.
Quan Capital, a healthcare-focused venture capital firm established by the founder of US-listed Chinese drug developer Zai Lab, has closed its second fund with $275 million in commitments.